Page last updated: 2024-09-02

carboxyatractyloside and Liver Steatosis

carboxyatractyloside has been researched along with Liver Steatosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, J; Choi, CS; Chun, SK; Han, C; Joseph, AM; Kalavalapalli, S; Kim, JS; Lee, HY; Lee, YJ; Mathews, CE; Morgan, D; Oh, SP; Park, HJ; Park, SY; Shiratsuchi, T; Someya, S; Sunny, NE; Terada, N; Wohlgemuth, SE; Zhang, Y1

Other Studies

1 other study(ies) available for carboxyatractyloside and Liver Steatosis

ArticleYear
Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance.
    Nature communications, 2017, 02-16, Volume: 8

    Topics: Adenine Nucleotide Translocator 2; Adenosine Triphosphate; Animals; Atractyloside; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Female; Glucose Clamp Technique; Hyperinsulinism; Insulin Resistance; Lipid Metabolism; Lipogenesis; Liver; Male; Mice; Mice, Knockout; Mitochondria, Liver; Mitochondrial Membranes; Non-alcoholic Fatty Liver Disease; Obesity; Protective Agents; Pyruvic Acid

2017